Go Deep
IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc. Score & Ratio Trend
| Date | Score | P/E | P/B | D/E | Price |
|---|---|---|---|---|---|
| Oct 2026 | 8,938 | 36.1 | 25.31 | 0.68 | 50,022.33 |
| Oct 2026 | 8,752 | 36.8 | 25.60 | 0.68 | 50,162.29 |
| Oct 2026 | 9,204 | 36.6 | 25.42 | 0.68 | 49,551.05 |
| Oct 2026 | 8,935 | 37.2 | 25.84 | 0.68 | 50,228.18 |
| Oct 2026 | 8,372 | 37.8 | 26.73 | 0.68 | 51,960.78 |
| Oct 2026 | 7,963 | 39.4 | 27.38 | 0.68 | 53,074.47 |
| Oct 2026 | 8,104 | 39.1 | 27.15 | 0.68 | 52,698.95 |
| Oct 2026 | 8,038 | 39.2 | 27.26 | 0.68 | 52,900.91 |
| Oct 2026 | 8,176 | 38.9 | 27.04 | 0.68 | 52,349.34 |
| Oct 2026 | 7,765 | 39.8 | 27.69 | 0.68 | 53,496.94 |
| Oct 2026 | 7,962 | 39.4 | 27.38 | 0.68 | 53,114.04 |
IDEXX Laboratories, Inc. Quarterly Results
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|---|
| Revenue | 1,216,585,000.0 | 1,140,820,000.0 | 1,090,579,000.0 | 1,105,239,000.0 |
| Net Profit | 338,412,000.0 | 278,446,000.0 | 248,188,000.0 | 274,610,000.0 |
| EPS | 4.3 | 3.5 | 3.1 | 3.4 |
IDEXX Laboratories, Inc. Revenue & Profit: Last 5 Years
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 4,303,702,000.0 | 3,897,504,000.0 | 3,660,953,000.0 | 3,367,324,000.0 | — |
| Net Profit | 1,059,464,000.0 | 887,867,000.0 | 845,042,000.0 | 679,089,000.0 | — |
| EPS | 13.2 | 10.8 | 10.2 | 8.1 | — |
IDEXX Laboratories, Inc. Balance Sheet
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Total Assets | 3,350,759,000.0 | 3,293,443,000.0 | 3,259,925,000.0 | 2,746,765,000.0 | — |
| Total Liabilities | 1,745,376,000.0 | 1,698,130,000.0 | 1,775,395,000.0 | 2,138,028,000.0 | — |
| Total Equity | 1,605,383,000.0 | 1,595,313,000.0 | 1,484,530,000.0 | 608,737,000.0 | — |
Owes vs Owns
IDEXX Laboratories, Inc. owed $0.53 for every $1 it owned in Jun 2026, down from $0.78 in Dec 2022.
| Period | Jun 2026 | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|---|
| Owes vs Owns | 0.53× | 0.52× | 0.52× | 0.54× | 0.78× |
Everything the company owes ÷ everything it owns. Below 1× it owns more than it owes; above 1× it owes more than it owns.
IDEXX Laboratories, Inc. Assets & Liabilities Breakdown (USD millions)
What it owns — Dec 2025
Cash & short-term investments 5.4%Receivables 20.7%Inventory 11.3%Fixed assets (tangible) 26.0%Intangible assets 15.6%Long-term investments 1.7%Other assets 19.3%
How it's funded — Dec 2025
Short-term debt 14.1%Long-term debt 11.2%Payables 3.3%Other liabilities 23.5%Shareholders' equity 47.9%
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
| Assets | ||||
| Cash & short-term investments | 180.1 | 288.3 | 453.9 | 112.5 |
| Receivables | 693.2 | 561.3 | 529.5 | 490.9 |
| Inventory | 377.8 | 381.9 | 380.3 | 367.8 |
| Fixed assets (tangible) | 870.6 | 829.3 | 817.7 | 768.1 |
| Intangible assets | 523.8 | 516.8 | 450.5 | 459.5 |
| Long-term investments | 58.5 | 57.7 | 56.2 | 55.5 |
| Other assets | 646.8 | 658.2 | 571.9 | 492.4 |
| Liabilities & equity | ||||
| Short-term debt | 473.0 | 417.8 | 325.0 | 654.0 |
| Long-term debt | 374.8 | 449.8 | 622.9 | 694.4 |
| Payables | 110.4 | 114.2 | 110.6 | 110.2 |
| Other liabilities | 787.1 | 716.3 | 716.9 | 679.4 |
| Shareholders' equity | 1,605.4 | 1,595.3 | 1,484.5 | 608.7 |
| Net tangible assets | 1,081.5 | 1,078.5 | 1,034.1 | 149.3 |
IDEXX Laboratories, Inc. Cash Flow
| Line Item | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Operating Activities | 1,181,805,000.0 | 929,001,000.0 | 906,510,000.0 | 542,984,000.0 | — |
| Investing Activities | -136,239,000.0 | -207,062,000.0 | -125,254,000.0 | -195,350,000.0 | — |
| Financing Activities | -1,164,964,000.0 | -878,073,000.0 | -441,996,000.0 | -370,936,000.0 | — |